Security key
46266A109
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 6,822,202
- Total 13F value
- $299,786,808
- Share change
- +88,460
- Put/Call ratio
- 1.4%
- SEC-reported price per share
- $43.94
- Number of holders
- 137
- Value change
- +$3,892,743
- Number of buys
- 91
- Number of sells
- 48
- Shares outstanding
- 12,797,137
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
137
Top holders
10
IRMD full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
IRADIMED CORP SEC filings
IRADIMED CORP company facts
Broader feeds
Reporting periods
Holder history for CUSIP 46266A109
Recent filing periods:
Ownership snapshot
Top reported holders of IRMD - IRADIMED CORP - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Nine Ten Capital Manageme...
Disclosed value leader
Nine Ten Capital Manageme...
Comparable rows
0/15
Latest evidence
31 Mar 2024
13F
Highest disclosed value: $35,604,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Nine Ten Capital Management LLC has the largest disclosed position value at $35.6M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Nine Ten Capital Management LLC's linked filing trail.
Disclosed position value
Top 5
Nine Ten Capital Management LLC
$35.6M
BlackRock Finance, Inc.
$28.98M
RENAISSANCE TECHNOLOGIES LLC
$25.22M
VANGUARD GROUP INC
$18.76M
Copeland Capital Management, LLC
$18.39M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Nine Ten Capital Management LLC |
13F
Company
|
—
denominator unverified
|
$35,604,000
809,366 shares
|
— | 31 Mar 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$28,978,413
658,750 shares
|
— | 31 Mar 2024 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
—
denominator unverified
|
$25,217,000
573,244 shares
|
— | 31 Mar 2024 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$18,760,723
426,477 shares
|
— | 31 Mar 2024 |
| Copeland Capital Management, LLC |
13F
Company
|
—
denominator unverified
|
$18,394,375
418,149 shares
|
— | 31 Mar 2024 |
| Soleus Capital Management, L.P. |
13F
Company
|
—
denominator unverified
|
$15,908,104
361,630 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
137
Shares
6,822,202
Rows available
137
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
125
Q2 2024 holders
137
Holder diff
12
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend